Loading the player...

15:24 Annenberg Center for Health Sciences

NEXT UP
Treating Asthma with Mepolizumab, Reslizumab, Benralizumab

Dupilumab Improves Symptoms for Severe Chronic Rhinosinusitis with Nasal Polyps

A Lancet study found that dupilumab may reduce nasal polyp size thus improving sinus symptoms...

Next Up In Asthma

Harnessing Physics to Target Asthma

Harnessing Physics to Target Asthma

ATS 2020: E-Cigarette Use May Impact Nasal Microbiome

ATS 2020: E-Cigarette Use May Impact Nasal Microbiome

Asthma Redefined: A Wide Spectrum

Asthma Redefined: A Wide Spectrum

Which Surgery Is Best for Chronic Rhinosinusitis with Nasal Polyps, Asthma

Which Surgery Is Best for Chronic Rhinosinusitis with Nasal Polyps, Asthma

Reslizumab Proves Effective in Treatment of Corticosteroid-Dependent Asthma

Reslizumab Proves Effective in Treatment of Corticosteroid-Dependent Asthma

FDA Approves Benralizumab Auto-Injector Pen For Severe Eosinophilic Asthma

FDA Approves Benralizumab Auto-Injector Pen For Severe Eosinophilic Asthma

Weight Likely Cause for One-Fourth of Asthma Cases in Kids With Obesity

Weight Likely Cause for One-Fourth of Asthma Cases in Kids With Obesity

Childhood Asthma Due to Traffic-Related Air Pollution

Childhood Asthma Due to Traffic-Related Air Pollution

Benralizumab Shows Benefits for Asthma, Nasal Polyp Treatment

Benralizumab Shows Benefits for Asthma, Nasal Polyp Treatment

FDA Approves First Generic Rescue Inhaler for Asthma Exacerbations

FDA Approves First Generic Rescue Inhaler for Asthma Exacerbations

COVID-19 Increased Asthma-Related Hospitalizations Among African American Children

COVID-19 Increased Asthma-Related Hospitalizations Among African American Children

Mometasone Combination Reduces Asthma Exacerbations

Mometasone Combination Reduces Asthma Exacerbations

Studies Assess Eczema Treatment for Asthma Symptoms

Studies Assess Eczema Treatment for Asthma Symptoms

Oral Corticosteroids Use May be Too High in Patients with Nasal Polyps, Severe Asthma

Oral Corticosteroids Use May be Too High in Patients with Nasal Polyps, Severe Asthma

Dupilumab Improves Symptoms for Severe Chronic Rhinosinusitis with Nasal Polyps

Dupilumab Improves Symptoms for Severe Chronic Rhinosinusitis with Nasal Polyps

Treating Asthma with Mepolizumab, Reslizumab, Benralizumab

Treating Asthma with Mepolizumab, Reslizumab, Benralizumab

Biologic Therapies in Asthma and New Areas for Research

Biologic Therapies in Asthma and New Areas for Research

Omalizumab Therapy and Sleep in Patients with Nasal Polyps

Omalizumab Therapy and Sleep in Patients with Nasal Polyps

Benralizumab Achieves Two Primary endpoints in Phase 3 Clinical Trial

Benralizumab Achieves Two Primary endpoints in Phase 3 Clinical Trial

FDA Approves Dupilumab in Convenient, Self-Administered Pen

FDA Approves Dupilumab in Convenient, Self-Administered Pen

FDA Issues Emergency Use Authorization for Asthma Treatment During Pandemic

FDA Issues Emergency Use Authorization for Asthma Treatment During Pandemic

NAVIGATOR: Tezepelumab Improves Lung Function, Asthma Scores

NAVIGATOR: Tezepelumab Improves Lung Function, Asthma Scores

CHEST 2020: Study Examines Mepolizumab in Severe Asthma Treatment

CHEST 2020: Study Examines Mepolizumab in Severe Asthma Treatment

Dupilumab Improves Smell for Patients with Chronic Rhinosinusitis with Nasal Polyps

Dupilumab Improves Smell for Patients with Chronic Rhinosinusitis with Nasal Polyps

Increased Risk of Osteoporosis with Oral, Inhaled Steroids

Increased Risk of Osteoporosis with Oral, Inhaled Steroids

NIH Updates Federal Asthma Guidelines

NIH Updates Federal Asthma Guidelines

Tracing the Origins of Childhood Asthma to Baby Immune Cells

Tracing the Origins of Childhood Asthma to Baby Immune Cells

FDA to Review BLA for Tezepelumab for Severe Asthma Treatment

FDA to Review BLA for Tezepelumab for Severe Asthma Treatment

FDA Approves Mepolizumab in CRSwNP

FDA Approves Mepolizumab in CRSwNP

Researchers Say Protein Could Help Treat Chronic Rhinosinusitis

Researchers Say Protein Could Help Treat Chronic Rhinosinusitis

Adding Dupilumab to Allergy Immunotherapy May Improve SCIT Tolerability

Adding Dupilumab to Allergy Immunotherapy May Improve SCIT Tolerability

EU Panel Recommends Approval of New Combo Inhaler for Uncontrolled Asthma

EU Panel Recommends Approval of New Combo Inhaler for Uncontrolled Asthma

Identifying Aspirin-Exacerbated Respiratory Disease

Identifying Aspirin-Exacerbated Respiratory Disease

ARS 2020: Dupilumab Effective in Treating CRSwNP Regardless of Sinus Surgery History

ARS 2020: Dupilumab Effective in Treating CRSwNP Regardless of Sinus Surgery History

OSMO: Asthma Improves in Nearly All Patients Switched to Mepolizumab

OSMO: Asthma Improves in Nearly All Patients Switched to Mepolizumab

New Therapy Shows Promise in Severe Asthma Patients with Low Eosinophils

New Therapy Shows Promise in Severe Asthma Patients with Low Eosinophils

CHEST 2020: Study Examines Use of Biologic Therapies in Patients with Severe Asthma

CHEST 2020: Study Examines Use of Biologic Therapies in Patients with Severe Asthma

Triple Therapy vs Dual Therapy Outcomes in Children, Adults with Asthma

Triple Therapy vs Dual Therapy Outcomes in Children, Adults with Asthma

FeNO May Help Predict Asthma Risk

FeNO May Help Predict Asthma Risk

Once-Daily, Triple Therapy Inhaler Gets New FDA Approval for Asthma

Once-Daily, Triple Therapy Inhaler Gets New FDA Approval for Asthma

Therapeutic Strategy Simplifies Asthma Management

Therapeutic Strategy Simplifies Asthma Management

Uncontrolled Asthma May Actually be Severe Reflux

Uncontrolled Asthma May Actually be Severe Reflux

Fevipiprant Fails Asthma Clinical Trials, Manufacturer Ceases Development

Fevipiprant Fails Asthma Clinical Trials, Manufacturer Ceases Development

ACAAI Makes Asthma Recommendations For Covid-19 Pandemic

ACAAI Makes Asthma Recommendations For Covid-19 Pandemic

FDA Grants Tezepelumab Priority Review as Asthma Treatment

FDA Grants Tezepelumab Priority Review as Asthma Treatment

Most Younger Asthma Patients Unprepared to Switch to Adult Care

Most Younger Asthma Patients Unprepared to Switch to Adult Care

Symptom Control Impacts Decisions to Discontinue Biologics for Asthma

Symptom Control Impacts Decisions to Discontinue Biologics for Asthma

Dupilumab Under FDA Review for New Pediatric Asthma Indication

Dupilumab Under FDA Review for New Pediatric Asthma Indication

Study Examines Challenges of Post-Hospitalization Asthma Exacerbation Risks

Study Examines Challenges of Post-Hospitalization Asthma Exacerbation Risks

Asthma: Getting It Right

Asthma: Getting It Right

Dupilumab Shows Good Safety, Efficacy for 3 Years in Moderate-to-Severe Asthma

Dupilumab Shows Good Safety, Efficacy for 3 Years in Moderate-to-Severe Asthma

Vaping and Asthma Exacerbations: Canadian Community Health Survey Data

Vaping and Asthma Exacerbations: Canadian Community Health Survey Data

Which Biologic is Best at Reducing Asthma Exacerbations?

Which Biologic is Best at Reducing Asthma Exacerbations?

EU Approves New Indication for Biologic in CRSwNP

EU Approves New Indication for Biologic in CRSwNP

FDA Approved Medications for the Treatment of Severe Asthma

FDA Approved Medications for the Treatment of Severe Asthma

Comparable Outcomes with Biologics, Bronchial Thermoplasty in Severe Asthma

Comparable Outcomes with Biologics, Bronchial Thermoplasty in Severe Asthma

Fixed-dose Combination Proves Beneficial in Asthma in Two Phase 3 Trials

Fixed-dose Combination Proves Beneficial in Asthma in Two Phase 3 Trials

FDA Approves New Self-Injected Omalizumab for Asthma

FDA Approves New Self-Injected Omalizumab for Asthma

New ATS Report Shows Significant Asthma Benefits Following Air Pollution Reduction

New ATS Report Shows Significant Asthma Benefits Following Air Pollution Reduction

Mepolizumab Gains European Approval in More Eosinophil-driven Diseases

Mepolizumab Gains European Approval in More Eosinophil-driven Diseases

Oral vs. Intranasal Glucocorticoids in Chronic Rhinosinusitis with Nasal Polyps

Oral vs. Intranasal Glucocorticoids in Chronic Rhinosinusitis with Nasal Polyps

Mepolizumab Receives Positive Opinions for CRSwNP, Eosinophil-driven Diseases

Mepolizumab Receives Positive Opinions for CRSwNP, Eosinophil-driven Diseases

Combination Tablet Improved Nasal Airflow in Allergic Rhinitis, Nasal Congestion

Combination Tablet Improved Nasal Airflow in Allergic Rhinitis, Nasal Congestion

Benralizumab, Mepolizumab Equally Improve Symptoms of Severe Eosinophilic Asthma

Benralizumab, Mepolizumab Equally Improve Symptoms of Severe Eosinophilic Asthma

Digital Inhaler With New Technology Approved in Europe

Digital Inhaler With New Technology Approved in Europe

COVID-19 Severity Not Connected to Asthma

COVID-19 Severity Not Connected to Asthma

Biologic Therapy in Asthma Reduces Exacerbations, Oral Corticosteroid Dosage

Biologic Therapy in Asthma Reduces Exacerbations, Oral Corticosteroid Dosage

PNN Combined with Functional Endoscopic Sinusitis Surgery Alleviates Symptoms Caused by Nasal Polyps

PNN Combined with Functional Endoscopic Sinusitis Surgery Alleviates Symptoms Caused by Nasal Polyps

Antibody Cocktail Prevents Cat Allergy Reaction in Patients with Asthma

Antibody Cocktail Prevents Cat Allergy Reaction in Patients with Asthma

Air Next Spirometer Cleared by the FDA for Asthma, COPD

Air Next Spirometer Cleared by the FDA for Asthma, COPD

Single-dose Auto-injector FDA Approved for CRwNP

Single-dose Auto-injector FDA Approved for CRwNP

New Clinical Practice Guideline on FeNo in Treatment of Asthma

New Clinical Practice Guideline on FeNo in Treatment of Asthma

Dupilumab Improves Airway Outcomes for Patients with Asthma, CRSwNP

Dupilumab Improves Airway Outcomes for Patients with Asthma, CRSwNP

Tezepelumab Produces “Meaningful” Reduction in Asthma Exacerbations

Tezepelumab Produces “Meaningful” Reduction in Asthma Exacerbations

Clinical Trial: Uncontrolled Asthma Inhaler Treatment Improves Quality of Life

Clinical Trial: Uncontrolled Asthma Inhaler Treatment Improves Quality of Life

FDA Approves Dupilumab for Children with Moderate-to-Severe Asthma

FDA Approves Dupilumab for Children with Moderate-to-Severe Asthma

FDA Approved Biologic Targets Unique Inflammatory Driver in Nasal Polyps

FDA Approved Biologic Targets Unique Inflammatory Driver in Nasal Polyps

New Tezepelumab Data Shows Improvements in Lung Function, Nasal Polyp Symptoms

New Tezepelumab Data Shows Improvements in Lung Function, Nasal Polyp Symptoms

Dupilumab Reduces Need for Surgery, Corticosteroid Use in CRSwNP

Dupilumab Reduces Need for Surgery, Corticosteroid Use in CRSwNP

Benralizumab Reduces Asthma Exacerbations in Those with Varying Blood Eosinophils

Benralizumab Reduces Asthma Exacerbations in Those with Varying Blood Eosinophils

Selecting Asthma Biologics: Which Therapies Are the Best Fit?

Selecting Asthma Biologics: Which Therapies Are the Best Fit?

CHEST 2020: CAPTAIN Trial Examines Association of Asthma Exacerbations with Lung Function

CHEST 2020: CAPTAIN Trial Examines Association of Asthma Exacerbations with Lung Function

Popular Asthma Treatment Reduces Hospitalization, Symptoms in COVID-19 Patients

Popular Asthma Treatment Reduces Hospitalization, Symptoms in COVID-19 Patients

New Classification Needed for Asthma Patients with Chronic Rhinosinusitis

New Classification Needed for Asthma Patients with Chronic Rhinosinusitis

Mepolizumab Effective for Nasal Polyps in Phase 3 Trial

Mepolizumab Effective for Nasal Polyps in Phase 3 Trial

MD /Alert Exclusives

Oral vs. Intranasal Glucocorticoids in Chronic Rhinosinusitis with Nasal Polyps

Oral vs. Intranasal Glucocorticoids in Chronic Rhinosinusitis with Nasal Polyps

Mepolizumab Gains European Approval in More Eosinophil-driven Diseases

Mepolizumab Gains European Approval in More Eosinophil-driven Diseases

Benralizumab Reduces Asthma Exacerbations in Those with Varying Blood Eosinophils

Benralizumab Reduces Asthma Exacerbations in Those with Varying Blood Eosinophils

Most Younger Asthma Patients Unprepared to Switch to Adult Care

Most Younger Asthma Patients Unprepared to Switch to Adult Care

Adding Dupilumab to Allergy Immunotherapy May Improve SCIT Tolerability

Adding Dupilumab to Allergy Immunotherapy May Improve SCIT Tolerability

FDA Approves Dupilumab for Children with Moderate-to-Severe Asthma

FDA Approves Dupilumab for Children with Moderate-to-Severe Asthma

New Tezepelumab Data Shows Improvements in Lung Function, Nasal Polyp Symptoms

New Tezepelumab Data Shows Improvements in Lung Function, Nasal Polyp Symptoms

Comparable Outcomes with Biologics, Bronchial Thermoplasty in Severe Asthma

Comparable Outcomes with Biologics, Bronchial Thermoplasty in Severe Asthma

Mometasone Combination Reduces Asthma Exacerbations

Mometasone Combination Reduces Asthma Exacerbations

Mepolizumab Receives Positive Opinions for CRSwNP, Eosinophil-driven Diseases

Mepolizumab Receives Positive Opinions for CRSwNP, Eosinophil-driven Diseases

Biologic Therapy in Asthma Reduces Exacerbations, Oral Corticosteroid Dosage

Biologic Therapy in Asthma Reduces Exacerbations, Oral Corticosteroid Dosage

Fixed-dose Combination Proves Beneficial in Asthma in Two Phase 3 Trials

Fixed-dose Combination Proves Beneficial in Asthma in Two Phase 3 Trials

Benralizumab, Mepolizumab Equally Improve Symptoms of Severe Eosinophilic Asthma

Benralizumab, Mepolizumab Equally Improve Symptoms of Severe Eosinophilic Asthma

Therapeutic Strategy Simplifies Asthma Management

Therapeutic Strategy Simplifies Asthma Management

FDA Approves Mepolizumab in CRSwNP

FDA Approves Mepolizumab in CRSwNP

FeNO May Help Predict Asthma Risk

FeNO May Help Predict Asthma Risk

Dupilumab Reduces Need for Surgery, Corticosteroid Use in CRSwNP

Dupilumab Reduces Need for Surgery, Corticosteroid Use in CRSwNP

Vaping and Asthma Exacerbations: Canadian Community Health Survey Data

Vaping and Asthma Exacerbations: Canadian Community Health Survey Data

Study Examines Challenges of Post-Hospitalization Asthma Exacerbation Risks

Study Examines Challenges of Post-Hospitalization Asthma Exacerbation Risks

Researchers Say Protein Could Help Treat Chronic Rhinosinusitis

Researchers Say Protein Could Help Treat Chronic Rhinosinusitis

FDA Grants Tezepelumab Priority Review as Asthma Treatment

FDA Grants Tezepelumab Priority Review as Asthma Treatment

Triple Therapy vs Dual Therapy Outcomes in Children, Adults with Asthma

Triple Therapy vs Dual Therapy Outcomes in Children, Adults with Asthma

OSMO: Asthma Improves in Nearly All Patients Switched to Mepolizumab

OSMO: Asthma Improves in Nearly All Patients Switched to Mepolizumab

NAVIGATOR: Tezepelumab Improves Lung Function, Asthma Scores

NAVIGATOR: Tezepelumab Improves Lung Function, Asthma Scores

FDA to Review BLA for Tezepelumab for Severe Asthma Treatment

FDA to Review BLA for Tezepelumab for Severe Asthma Treatment

Benralizumab Shows Benefits for Asthma, Nasal Polyp Treatment

Benralizumab Shows Benefits for Asthma, Nasal Polyp Treatment

COVID-19 Increased Asthma-Related Hospitalizations Among African American Children

COVID-19 Increased Asthma-Related Hospitalizations Among African American Children

FDA Approves New Self-Injected Omalizumab for Asthma

FDA Approves New Self-Injected Omalizumab for Asthma

Antibody Cocktail Prevents Cat Allergy Reaction in Patients with Asthma

Antibody Cocktail Prevents Cat Allergy Reaction in Patients with Asthma

Omalizumab Therapy and Sleep in Patients with Nasal Polyps

Omalizumab Therapy and Sleep in Patients with Nasal Polyps

Dupilumab Improves Airway Outcomes for Patients with Asthma, CRSwNP

Dupilumab Improves Airway Outcomes for Patients with Asthma, CRSwNP

Dupilumab Under FDA Review for New Pediatric Asthma Indication

Dupilumab Under FDA Review for New Pediatric Asthma Indication

Tezepelumab Produces “Meaningful” Reduction in Asthma Exacerbations

Tezepelumab Produces “Meaningful” Reduction in Asthma Exacerbations

Popular Asthma Treatment Reduces Hospitalization, Symptoms in COVID-19 Patients

Popular Asthma Treatment Reduces Hospitalization, Symptoms in COVID-19 Patients

Symptom Control Impacts Decisions to Discontinue Biologics for Asthma

Symptom Control Impacts Decisions to Discontinue Biologics for Asthma

Combination Tablet Improved Nasal Airflow in Allergic Rhinitis, Nasal Congestion

Combination Tablet Improved Nasal Airflow in Allergic Rhinitis, Nasal Congestion

NIH Updates Federal Asthma Guidelines

NIH Updates Federal Asthma Guidelines

FDA Approved Biologic Targets Unique Inflammatory Driver in Nasal Polyps

FDA Approved Biologic Targets Unique Inflammatory Driver in Nasal Polyps

New Therapy Shows Promise in Severe Asthma Patients with Low Eosinophils

New Therapy Shows Promise in Severe Asthma Patients with Low Eosinophils

Benralizumab Achieves Two Primary endpoints in Phase 3 Clinical Trial

Benralizumab Achieves Two Primary endpoints in Phase 3 Clinical Trial

Increased Risk of Osteoporosis with Oral, Inhaled Steroids

Increased Risk of Osteoporosis with Oral, Inhaled Steroids

CHEST 2020: Study Examines Use of Biologic Therapies in Patients with Severe Asthma

CHEST 2020: Study Examines Use of Biologic Therapies in Patients with Severe Asthma

CHEST 2020: Study Examines Mepolizumab in Severe Asthma Treatment

CHEST 2020: Study Examines Mepolizumab in Severe Asthma Treatment

CHEST 2020: CAPTAIN Trial Examines Association of Asthma Exacerbations with Lung Function

CHEST 2020: CAPTAIN Trial Examines Association of Asthma Exacerbations with Lung Function

ARS 2020: Dupilumab Effective in Treating CRSwNP Regardless of Sinus Surgery History

ARS 2020: Dupilumab Effective in Treating CRSwNP Regardless of Sinus Surgery History

Dupilumab Shows Good Safety, Efficacy for 3 Years in Moderate-to-Severe Asthma

Dupilumab Shows Good Safety, Efficacy for 3 Years in Moderate-to-Severe Asthma

Once-Daily, Triple Therapy Inhaler Gets New FDA Approval for Asthma

Once-Daily, Triple Therapy Inhaler Gets New FDA Approval for Asthma

New Classification Needed for Asthma Patients with Chronic Rhinosinusitis

New Classification Needed for Asthma Patients with Chronic Rhinosinusitis

EU Approves New Indication for Biologic in CRSwNP

EU Approves New Indication for Biologic in CRSwNP

FDA Issues Emergency Use Authorization for Asthma Treatment During Pandemic

FDA Issues Emergency Use Authorization for Asthma Treatment During Pandemic

COVID-19 Severity Not Connected to Asthma

COVID-19 Severity Not Connected to Asthma

Digital Inhaler With New Technology Approved in Europe

Digital Inhaler With New Technology Approved in Europe

FDA Approves Dupilumab in Convenient, Self-Administered Pen

FDA Approves Dupilumab in Convenient, Self-Administered Pen

Oral Corticosteroids Use May be Too High in Patients with Nasal Polyps, Severe Asthma

Oral Corticosteroids Use May be Too High in Patients with Nasal Polyps, Severe Asthma

Selecting Asthma Biologics: Which Therapies Are the Best Fit?

Selecting Asthma Biologics: Which Therapies Are the Best Fit?

Clinical Trial: Uncontrolled Asthma Inhaler Treatment Improves Quality of Life

Clinical Trial: Uncontrolled Asthma Inhaler Treatment Improves Quality of Life

ATS 2020: E-Cigarette Use May Impact Nasal Microbiome

ATS 2020: E-Cigarette Use May Impact Nasal Microbiome

Biologic Therapies in Asthma and New Areas for Research

Biologic Therapies in Asthma and New Areas for Research

EU Panel Recommends Approval of New Combo Inhaler for Uncontrolled Asthma

EU Panel Recommends Approval of New Combo Inhaler for Uncontrolled Asthma

Mepolizumab Effective for Nasal Polyps in Phase 3 Trial

Mepolizumab Effective for Nasal Polyps in Phase 3 Trial

Dupilumab Improves Smell for Patients with Chronic Rhinosinusitis with Nasal Polyps

Dupilumab Improves Smell for Patients with Chronic Rhinosinusitis with Nasal Polyps

ACAAI Makes Asthma Recommendations For Covid-19 Pandemic

ACAAI Makes Asthma Recommendations For Covid-19 Pandemic

PNN Combined with Functional Endoscopic Sinusitis Surgery Alleviates Symptoms Caused by Nasal Polyps

PNN Combined with Functional Endoscopic Sinusitis Surgery Alleviates Symptoms Caused by Nasal Polyps

FDA Approves First Generic Rescue Inhaler for Asthma Exacerbations

FDA Approves First Generic Rescue Inhaler for Asthma Exacerbations

Which Biologic is Best at Reducing Asthma Exacerbations?

Which Biologic is Best at Reducing Asthma Exacerbations?

Air Next Spirometer Cleared by the FDA for Asthma, COPD

Air Next Spirometer Cleared by the FDA for Asthma, COPD

Which Surgery Is Best for Chronic Rhinosinusitis with Nasal Polyps, Asthma

Which Surgery Is Best for Chronic Rhinosinusitis with Nasal Polyps, Asthma

Fevipiprant Fails Asthma Clinical Trials, Manufacturer Ceases Development

Fevipiprant Fails Asthma Clinical Trials, Manufacturer Ceases Development

Reslizumab Proves Effective in Treatment of Corticosteroid-Dependent Asthma

Reslizumab Proves Effective in Treatment of Corticosteroid-Dependent Asthma

New ATS Report Shows Significant Asthma Benefits Following Air Pollution Reduction

New ATS Report Shows Significant Asthma Benefits Following Air Pollution Reduction

Dupilumab Improves Symptoms for Severe Chronic Rhinosinusitis with Nasal Polyps

Dupilumab Improves Symptoms for Severe Chronic Rhinosinusitis with Nasal Polyps

FDA Approves Benralizumab Auto-Injector Pen For Severe Eosinophilic Asthma

FDA Approves Benralizumab Auto-Injector Pen For Severe Eosinophilic Asthma

Featured Asthma Videos

Asthma: Unmasking the Culprit

Asthma: Unmasking the Culprit

Asthma Redefined: A Wide Spectrum

Asthma Redefined: A Wide Spectrum

Asthma: Getting It Right

Asthma: Getting It Right

Breaking Research

New Clinical Practice Guideline on FeNo in Treatment of Asthma

New Clinical Practice Guideline on FeNo in Treatment of Asthma

Tracing the Origins of Childhood Asthma to Baby Immune Cells

Tracing the Origins of Childhood Asthma to Baby Immune Cells

Childhood Asthma Due to Traffic-Related Air Pollution

Childhood Asthma Due to Traffic-Related Air Pollution

Weight Likely Cause for One-Fourth of Asthma Cases in Kids With Obesity

Weight Likely Cause for One-Fourth of Asthma Cases in Kids With Obesity

Harnessing Physics to Target Asthma

Harnessing Physics to Target Asthma

Nasal Polyps

Oral vs. Intranasal Glucocorticoids in Chronic Rhinosinusitis with Nasal Polyps

Oral vs. Intranasal Glucocorticoids in Chronic Rhinosinusitis with Nasal Polyps

Adding Dupilumab to Allergy Immunotherapy May Improve SCIT Tolerability

Adding Dupilumab to Allergy Immunotherapy May Improve SCIT Tolerability

New Tezepelumab Data Shows Improvements in Lung Function, Nasal Polyp Symptoms

New Tezepelumab Data Shows Improvements in Lung Function, Nasal Polyp Symptoms

Mepolizumab Receives Positive Opinions for CRSwNP, Eosinophil-driven Diseases

Mepolizumab Receives Positive Opinions for CRSwNP, Eosinophil-driven Diseases

FDA Approves Mepolizumab in CRSwNP

FDA Approves Mepolizumab in CRSwNP

Dupilumab Reduces Need for Surgery, Corticosteroid Use in CRSwNP

Dupilumab Reduces Need for Surgery, Corticosteroid Use in CRSwNP

Researchers Say Protein Could Help Treat Chronic Rhinosinusitis

Researchers Say Protein Could Help Treat Chronic Rhinosinusitis

OSMO: Asthma Improves in Nearly All Patients Switched to Mepolizumab

OSMO: Asthma Improves in Nearly All Patients Switched to Mepolizumab

Benralizumab Shows Benefits for Asthma, Nasal Polyp Treatment

Benralizumab Shows Benefits for Asthma, Nasal Polyp Treatment

FDA Approves New Self-Injected Omalizumab for Asthma

FDA Approves New Self-Injected Omalizumab for Asthma

Omalizumab Therapy and Sleep in Patients with Nasal Polyps

Omalizumab Therapy and Sleep in Patients with Nasal Polyps

Dupilumab Improves Airway Outcomes for Patients with Asthma, CRSwNP

Dupilumab Improves Airway Outcomes for Patients with Asthma, CRSwNP

Combination Tablet Improved Nasal Airflow in Allergic Rhinitis, Nasal Congestion

Combination Tablet Improved Nasal Airflow in Allergic Rhinitis, Nasal Congestion

FDA Approved Biologic Targets Unique Inflammatory Driver in Nasal Polyps

FDA Approved Biologic Targets Unique Inflammatory Driver in Nasal Polyps

Benralizumab Achieves Two Primary endpoints in Phase 3 Clinical Trial

Benralizumab Achieves Two Primary endpoints in Phase 3 Clinical Trial

ARS 2020: Dupilumab Effective in Treating CRSwNP Regardless of Sinus Surgery History

ARS 2020: Dupilumab Effective in Treating CRSwNP Regardless of Sinus Surgery History

New Classification Needed for Asthma Patients with Chronic Rhinosinusitis

New Classification Needed for Asthma Patients with Chronic Rhinosinusitis

EU Approves New Indication for Biologic in CRSwNP

EU Approves New Indication for Biologic in CRSwNP

Single-dose Auto-injector FDA Approved for CRwNP

Single-dose Auto-injector FDA Approved for CRwNP

Oral Corticosteroids Use May be Too High in Patients with Nasal Polyps, Severe Asthma

Oral Corticosteroids Use May be Too High in Patients with Nasal Polyps, Severe Asthma

ATS 2020: E-Cigarette Use May Impact Nasal Microbiome

ATS 2020: E-Cigarette Use May Impact Nasal Microbiome

Mepolizumab Effective for Nasal Polyps in Phase 3 Trial

Mepolizumab Effective for Nasal Polyps in Phase 3 Trial

Dupilumab Improves Smell for Patients with Chronic Rhinosinusitis with Nasal Polyps

Dupilumab Improves Smell for Patients with Chronic Rhinosinusitis with Nasal Polyps

Identifying Aspirin-Exacerbated Respiratory Disease

Identifying Aspirin-Exacerbated Respiratory Disease

Which Surgery Is Best for Chronic Rhinosinusitis with Nasal Polyps, Asthma

Which Surgery Is Best for Chronic Rhinosinusitis with Nasal Polyps, Asthma

Dupilumab Improves Symptoms for Severe Chronic Rhinosinusitis with Nasal Polyps

Dupilumab Improves Symptoms for Severe Chronic Rhinosinusitis with Nasal Polyps

Triad Asthma and Nasal Polyps

Triad Asthma and Nasal Polyps

Curated For You

Studies Assess Eczema Treatment for Asthma Symptoms

Studies Assess Eczema Treatment for Asthma Symptoms

Uncontrolled Asthma May Actually be Severe Reflux

Uncontrolled Asthma May Actually be Severe Reflux

Treating Asthma with Mepolizumab, Reslizumab, Benralizumab

Treating Asthma with Mepolizumab, Reslizumab, Benralizumab

Identifying Aspirin-Exacerbated Respiratory Disease

Identifying Aspirin-Exacerbated Respiratory Disease

FDA Approved Medications for the Treatment of Severe Asthma

FDA Approved Medications for the Treatment of Severe Asthma

Mario Castro Presents Severe Asthma Data from the Severe Asthma Research Program

Mario Castro Presents Severe Asthma Data from the Severe Asthma Research Program

Mount Sinai Research Examines the Relationship Between Asthma Control and Depression

Mount Sinai Research Examines the Relationship Between Asthma Control and Depression

Optimizing Severe Asthma Care with Novel Treatments

Optimizing Severe Asthma Care with Novel Treatments

Adipose Hormone May Play Role in Obesity-Related Asthma

Adipose Hormone May Play Role in Obesity-Related Asthma

Triad Asthma and Nasal Polyps

Triad Asthma and Nasal Polyps